Mumbai, 13 November 2025 – Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Science Fund I, has invested ₹400 million in Mediversal Healthcare, a fast-growing multi-specialty hospital chain headquartered in Patna. The round also saw participation from Asha Ventures, an impact-focused fund.
The capital infusion will support organic and inorganic expansion across Eastern India, enabling Mediversal to scale its footprint and deepen access to affordable, high-quality healthcare in underserved regions.
“Healthcare remains a high-conviction theme for us,” said Ashish Ranjan, Director, Kotak Alts. “Mediversal’s blend of clinical excellence, affordability, and regional relevance makes them a natural partner for long-term value creation.”
Founded in 2020 by Navneet Ranjan, Bhanu Pratap, and Jayant Gandhi, Mediversal currently operates a 200+ bed NABH-certified facility in Patna and has served over 60,000 patients in the past year. The company is now expanding into neighboring districts with a focus on patient-centric care, modern infrastructure, and scalable systems.
“This investment accelerates our mission to bring dignified care closer to home,” said Bhanu Pratap, Co-founder & CEO, Mediversal. “We’re expanding across Bihar and Eastern India while strengthening our tech backbone to ensure consistent quality at every location.”
Mediversal is among the few healthcare providers in Eastern India to hold Full NABH Certification, IDCCM & IDCCN Compliance, and CAHO ACE Accreditation—underscoring its commitment to clinical excellence and operational rigor.
